OncoPharm
John Bossaer
Add to My Podcasts
Episodes
About
Reviews
Promote
Entrectinib & Fedratinib
19 minutes
Posted Aug 22, 2019 at 5:00 pm.
0:00
19:03
Add to My Queue
Download
MP3
Share
episode
Share at current time
Show notes
Running through the drug information highlights of the latest approved #oncopharm agents: entrectinib and fedratinib.
Previous
E1912: Ibrutinib/rituximab vs. FCR in CLL
Next
Irinotecan
← See all 273 episodes of OncoPharm